Drug triggers body's mechanism to reverse aging effect on memory process
A drug made to enhance memory appears to trigger a natural mechanism in the
brain that fully reverses age-related memory loss, even after the drug
itself has left the body, according to researchers at UC Irvine.
Professors Christine Gall and Gary Lynch, along with Associate Researcher
Julie Lauterborn, were among a group of scientists who conducted studies on
rats with a class of drugs known as ampakines. Ampakines were developed in
the early 1990s by UC researchers, including Lynch, to treat age-related
memory impairment and may be useful for treating a number of central
nervous system disorders, such as Alzheimer�s disease and schizophrenia. In
this study, the researchers showed that ampakine drugs continue to reverse
the effects of aging on a brain mechanism thought to underlie learning and
memory even after they are no longer in the body. They do so by boosting
the production of a naturally occurring protein in the brain necessary for
long-term memory formation.
The study appears in the August issue of the Journal of Neurophysiology.
This is a significant discovery,� said Gall, professor of anatomy and
neurobiology. �Our results indicate the exciting possibility that ampakines
could be used to treat learning and memory loss associated with normal aging.�
ver nota
Nootrópicos (smartdrugs, drogas inteligentes, potenciadores cognitivos) son sustancias artificiales (medicamentos como piracetam, hydergina, citicolina, fosfatidilserina, vinpocetina, etc.) o naturales (suplementos nutricionales, vitaminas, aminoácidos, hormonas, hierbas, etc. como vitaminas B, piroglutamato, Gingko Biloba, fenilalanina, DHEA, pregnenolona, etc.) que se utilizan para mejorar la capacidad cognitiva (memoria, atención, etc.) en personas con trastornos o normales.
